"In patients with low-to-moderate pretest probability of malignancy (5%-60%) and an indeterminate solitary pulmonary nodule (SPN) that measures at least 8 to 10 mm in diameter, we recommend that fluorodeoxyglucose (FDG)-positron emission tomography (PET) imaging should be performed to characterize the nodule.
"In patients with an SPN that has a high pretest probability of malignancy (> 60%), or patients with a subcentimeter nodule that measures < 8 to 10 mm in diameter, we suggest that FDG-PET not be performed to characterize the nodule."
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.